IBT
International Biotechnology Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $7.3M | Hold |
21,000
| – | – | 2.46% | 15 |
|
|
2023
Q2 | $7.39M | Sell |
21,000
-12,000
| -36% | -$4.22M | 2.25% | 14 |
|
|
2023
Q1 | $10.4M | Buy |
+33,000
| New | +$10.4M | 2.9% | 10 |
|
|
2022
Q2 | – | Sell |
-25,122
| Closed | -$3.23M | – | 81 |
|
|
2022
Q1 | $3.23M | Sell |
25,122
-52,100
| -67% | -$6.69M | 0.73% | 33 |
|
|
2021
Q4 | $17M | Hold |
77,222
| – | – | 3.78% | 10 |
|
|
2021
Q3 | $14M | Buy |
77,222
+12,400
| +19% | +$2.25M | 3.38% | 11 |
|
|
2021
Q2 | $13.1M | Sell |
64,822
-20,500
| -24% | -$4.13M | 3.45% | 10 |
|
|
2021
Q1 | $18.3M | Sell |
85,322
-12,000
| -12% | -$2.58M | 4.85% | 8 |
|
|
2020
Q4 | $23M | Buy |
97,322
+32,500
| +50% | +$7.67M | 6.28% | 3 |
|
|
2020
Q3 | $17.6M | Hold |
64,822
| – | – | 5.69% | 6 |
|
|
2020
Q2 | $18.5M | Sell |
64,822
-13,000
| -17% | -$3.71M | 6.14% | 4 |
|
|
2020
Q1 | $18.5M | Sell |
77,822
-15,600
| -17% | -$3.71M | 8.44% | 1 |
|
|
2019
Q4 | $20.4M | Buy |
93,422
+9,400
| +11% | +$2.06M | 7.36% | 1 |
|
|
2019
Q3 | $14.2M | Sell |
84,022
-1,000
| -1% | -$169K | 6.58% | 3 |
|
|
2019
Q2 | $15.6M | Buy |
85,022
+33,900
| +66% | +$6.21M | 5.78% | 2 |
|
|
2019
Q1 | $9.4M | Sell |
51,122
-39,000
| -43% | -$7.17M | 3.47% | 6 |
|
|
2018
Q4 | $11.7M | Buy |
90,122
+22,400
| +33% | +$2.91M | 7.28% | 2 |
|
|
2018
Q3 | $10M | Sell |
67,722
-15,500
| -19% | -$2.29M | 4.76% | 4 |
|
|
2018
Q2 | $14.1M | Buy |
83,222
+15,000
| +22% | +$2.55M | 5.43% | 3 |
|
|
2018
Q1 | $11.1M | Sell |
68,222
-7,200
| -10% | -$1.17M | 4.34% | 8 |
|
|
2017
Q4 | $11.3M | Sell |
75,422
-13,300
| -15% | -$1.99M | 3.99% | 6 |
|
|
2017
Q3 | $13.5M | Sell |
88,722
-46,800
| -35% | -$7.11M | 5.25% | 4 |
|
|
2017
Q2 | $17.5M | Buy |
135,522
+13,000
| +11% | +$1.68M | 6.64% | 3 |
|
|
2017
Q1 | $13.4M | Buy |
122,522
+17,000
| +16% | +$1.86M | 5.13% | 6 |
|
|
2016
Q4 | $7.78M | Buy |
+105,522
| New | +$7.78M | 3.5% | 11 |
|